Interpace Biosciences, Inc. Common Stock
IDXG
IDXG was delisted on the 24th of February, 2021.
19 hedge funds and large institutions have $2.98M invested in Interpace Biosciences, Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 5 closing their positions.
14% less funds holding
Funds holding: 22 → 19 (-3)
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
74% less capital invested
Capital invested by funds: $11.5M → $2.98M (-$8.48M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$14K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.8K |
| 3 |
Bank of New York Mellon
New York
|
+$2.23K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$111 |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$111 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SKK
Shepherd Kaplan Krochuk
Boston,
Massachusetts
|
-$195K |
| 2 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
-$112K |
| 3 |
AA
Ancora Advisors
Cleveland,
Ohio
|
-$50.1K |
| 4 |
MA
Minerva Advisors
Bala Cynwyd,
Pennsylvania
|
-$41K |
| 5 |
ANTB
AMG National Trust Bank
Greenwood Village,
Colorado
|
-$39K |
IDXG Hedge Fund Activity: Q4 2015 in Review
19 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Interpace Biosciences, Inc. Common Stock (IDXG) for Q4 2015, worth a combined $2.98M — down 74% from $11.5M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of IDXG and 2 opened new positions — a net loss of 3 holders — while 5 trimmed existing stakes and 3 added.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $14K. The largest seller was Shepherd Kaplan Krochuk, exiting entirely with an estimated $195K sold.
- 19 institutional investors held Interpace Biosciences, Inc. Common Stock (IDXG) as of Q4 2015, down from 22 in Q3 2015.
- Funds reported $2.98M of Interpace Biosciences, Inc. Common Stock stock for Q4 2015, down 74% quarter-over-quarter.
- 2 funds opened new Interpace Biosciences, Inc. Common Stock positions in Q4 2015 and 5 closed out, a net change of -3 holders.
- The largest Interpace Biosciences, Inc. Common Stock buyer in Q4 2015 was Two Sigma Securities, an estimated $14K added.
- The largest Interpace Biosciences, Inc. Common Stock seller in Q4 2015 was Shepherd Kaplan Krochuk, an estimated $195K sold.
Based on aggregated 13F filings for Q4 2015.